Axe Compute Sells Helomics, Goes All-In on GPU-as-a-Service
Axe Compute has sold its Helomics cancer diagnostics subsidiary to DataMEDS AI in an all-stock deal, completing its transformation into a pure-play GPU-as-a-Service neocloud. The move clears the company’s legacy portfolio but raises real questions about competitive differentiation and financial sustainability in a crowded AI infrastructure market. ECI Research examines what enterprise buyers and developers should watch.
Axe Compute Sells Helomics, Goes All-In on GPU-as-a-Service Read More »